BACKGROUND: Dengue virus infection causes a spectrum of clinical manifestations, usually classified according to the World Health Organization (WHO) guidelines into dengue fever (DF) and dengue hemorrhagic fever (DHF). The ability of these guidelines to categorize severe dengue illness has recently been questioned. METHODS: We evaluated dengue case definitions in a prospective study at a pediatric hospital in Bangkok, Thailand, during 1994-2005. One thousand thirteen children were enrolled within the first 3 days after onset of fever and observed with standardized data collection. Cases were classified on the basis of application of the strict WHO criteria. All dengue virus infections were laboratory confirmed. We retrospectively grouped patients on the basis of whether they received significant intervention based on fluid replacement and/or requirements for blood transfusion. RESULTS: Eighty-five (58%) of 150 persons with DHF, 40 (15%) of 264 with DF, and 73 (12%) of 599 with other febrile illnesses (OFIs) received significant intervention. Sixty-eight percent of dengue cases requiring intervention met strict WHO criteria for DHF. In contrast, only 1% of OFI cases met WHO criteria for DHF. Plasma leakage and thrombocytopenia were the 2 components contributing to the specificity of the WHO case definition and identified dengue cases that required intervention. Hemorrhagic tendency did not reliably differentiate DF and DHF. In DF cases, thrombocytopenia and bleeding were associated with severity. CONCLUSIONS: Dengue illness is heterogeneous in severity, and severe clinical features occurred in patients whose cases were not characterized as DHF. The WHO case definition of DHF demonstrated sensitivity of 62% and specificity of 92% for identification of dengue illness requiring intervention, without the need for laboratory confirmation of dengue virus infection, in an area of endemicity.
BACKGROUND:Dengue virus infection causes a spectrum of clinical manifestations, usually classified according to the World Health Organization (WHO) guidelines into dengue fever (DF) and dengue hemorrhagic fever (DHF). The ability of these guidelines to categorize severe dengue illness has recently been questioned. METHODS: We evaluated dengue case definitions in a prospective study at a pediatric hospital in Bangkok, Thailand, during 1994-2005. One thousand thirteen children were enrolled within the first 3 days after onset of fever and observed with standardized data collection. Cases were classified on the basis of application of the strict WHO criteria. All dengue virus infections were laboratory confirmed. We retrospectively grouped patients on the basis of whether they received significant intervention based on fluid replacement and/or requirements for blood transfusion. RESULTS: Eighty-five (58%) of 150 persons with DHF, 40 (15%) of 264 with DF, and 73 (12%) of 599 with other febrile illnesses (OFIs) received significant intervention. Sixty-eight percent of dengue cases requiring intervention met strict WHO criteria for DHF. In contrast, only 1% of OFI cases met WHO criteria for DHF. Plasma leakage and thrombocytopenia were the 2 components contributing to the specificity of the WHO case definition and identified dengue cases that required intervention. Hemorrhagic tendency did not reliably differentiate DF and DHF. In DF cases, thrombocytopenia and bleeding were associated with severity. CONCLUSIONS: Dengue illness is heterogeneous in severity, and severe clinical features occurred in patients whose cases were not characterized as DHF. The WHO case definition of DHF demonstrated sensitivity of 62% and specificity of 92% for identification of dengue illness requiring intervention, without the need for laboratory confirmation of dengue virus infection, in an area of endemicity.
Authors: Daniel H Libraty; Timothy P Endy; Huo-Shu H Houng; Sharone Green; Siripen Kalayanarooj; Saroj Suntayakorn; Wanya Chansiriwongs; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman Journal: J Infect Dis Date: 2002-04-16 Impact factor: 5.226
Authors: E Harris; E Videa; L Pérez; E Sandoval; Y Téllez; M L Pérez; R Cuadra; J Rocha; W Idiaquez; R E Alonso; M A Delgado; L A Campo; F Acevedo; A Gonzalez; J J Amador; A Balmaseda Journal: Am J Trop Med Hyg Date: 2000 Jul-Aug Impact factor: 2.345
Authors: Xuan Thanh Phuong Cao; Thi Nhan Ngo; Rachel Kneen; Delia Bethell; Thi Dep Le; Thi Thuy Nga Nguyen; Thi Thu Thuy Pham; Dinh Luat Truong; Tom Solomon; Bridget Wills; Christopher M Parry Journal: Trop Med Int Health Date: 2004-05 Impact factor: 2.622
Authors: Xuan Thanh Phuong Cao; Thi Nhan Ngo; Bridget Wills; Rachel Kneen; Thi Thanh Ha Nguyen; Thi Tuyet Mai Ta; Thi Thanh Huynh Tran; Thi Kim Lien Doan; Tom Solomon; Julie A Simpson; Nicholas J White; Jeremy J Farrar Journal: Trop Med Int Health Date: 2002-02 Impact factor: 2.622
Authors: T Solomon; N M Dung; D W Vaughn; R Kneen; L T Thao; B Raengsakulrach; H T Loan; N P Day; J Farrar; K S Myint; M J Warrell; W S James; A Nisalak; N J White Journal: Lancet Date: 2000-03-25 Impact factor: 79.321
Authors: D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; T P Endy; B Raengsakulrach; A L Rothman; F A Ennis; A Nisalak Journal: J Infect Dis Date: 2000-01 Impact factor: 5.226
Authors: Anon Srikiatkhachorn; Anchalee Krautrachue; Warangkana Ratanaprakarn; Lawan Wongtapradit; Narong Nithipanya; Siripen Kalayanarooj; Ananda Nisalak; Stephen J Thomas; Robert V Gibbons; Mammen P Mammen; Daniel H Libraty; Francis A Ennis; Alan L Rothman; Sharone Green Journal: Pediatr Infect Dis J Date: 2007-04 Impact factor: 2.129
Authors: Cornelia A M van de Weg; Eric C M van Gorp; Mohamad Supriatna; Augustinus Soemantri; Albert D M E Osterhaus; Byron E E Martina Journal: Am J Trop Med Hyg Date: 2012-01 Impact factor: 2.345
Authors: Anon Srikiatkhachorn; Alan L Rothman; Robert V Gibbons; Nopporn Sittisombut; Prida Malasit; Francis A Ennis; Suchitra Nimmannitya; Siripen Kalayanarooj Journal: Clin Infect Dis Date: 2011-08-10 Impact factor: 9.079
Authors: James A Potts; Stephen J Thomas; Anon Srikiatkhachorn; Pra-on Supradish; Wenjun Li; Ananda Nisalak; Suchitra Nimmannitya; Timothy P Endy; Daniel H Libraty; Robert V Gibbons; Sharone Green; Alan L Rothman; Siripen Kalayanarooj Journal: Am J Trop Med Hyg Date: 2010-10 Impact factor: 2.345
Authors: Eric S Halsey; Stalin Vilcarromero; Brett M Forshey; Claudio Rocha; Isabel Bazan; Steven T Stoddard; Tadeusz J Kochel; Martin Casapia; Thomas W Scott; Amy C Morrison Journal: Am J Trop Med Hyg Date: 2013-05-28 Impact factor: 2.345
Authors: Meta Michels; Uun Sumardi; Quirijn de Mast; Hadi Jusuf; Mita Puspita; Intan Mauli Warma Dewi; Sylvia Sinarta; Bachti Alisjahbana; André J A M van der Ven Journal: PLoS Negl Trop Dis Date: 2013-06-13
Authors: O Horstick; J Farrar; L Lum; E Martinez; J L San Martin; J Ehrenberg; R Velayudhan; A Kroeger Journal: Pathog Glob Health Date: 2012-05 Impact factor: 2.894